Skip to main content
. 2022 Jul 29;13:951214. doi: 10.3389/fimmu.2022.951214

Figure 8.

Figure 8

The prognostic value of CAFS-score in immunotherapy from TCGA cohort. (A–D) TIDE, MSI, T cell exclusion, and T cell dysfunction score in two CAFS-score subgroup, respectively. (E) ROC analysis of CAFS-score, TIDE, and TIS on OS in GC cohort. ***P<0.001, ns, P>0.05.